Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32861574.
- Also identified by DOI 10.1016/j.eururo.2020.08.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The similar clinical behavior, overlapping therapeutic patterns, and several clinical trials addressing the neoadjuvant and first-line therapy settings for bladder cancer support the call for a more uniform definition of "locally advanced" disease. We highlight the diverse therapeutic opportunities that patients with locally advanced bladder cancer may receive at present. Multimodal management, and post-therapy surgery in particular, may still have a role in selected patients.
Medical subject headings
- Carcinoma, Transitional Cell
- Urinary Bladder Neoplasms